OVERALL SURVIVAL OF NEWLY DIAGNOSED GLIOBLASTOMA PATIENTS TREATED BY STANDARD THERAPY IN COMPARISON TO STANDARD THERAPY PLUS TUMOR TREATING FIELDS

被引：0
|
作者：
Rulseh, Aaron [1 ]
Derner, Adam [1 ]
Sroubek, Jan [1 ]
Klener, Jan [1 ]
Vymazal, Josef [1 ]
机构：
[1] Na Homolce Hosp, Prague, Czech Republic
来源：
NEURO-ONCOLOGY | 2020年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CTNI-73
引用
收藏
页码：59 / 59
页数：1
相关论文
共 50 条
  • [1] Overall survival of glioblastoma patients treated by standard therapy in comparison to standard therapy plus tumor treating fields
    Rulseh, Aaron
    Derner, Adam
    Sroubek, Jan
    Klener, Jan
    Vymazal, Josef
    [J]. CANCER RESEARCH, 2020, 80 (16)
  • [2] Compliance of Tumor Treating Fields Therapy and Overall Survival in Glioblastoma
    Wong, Eric
    Fong, Johnson
    Lok, Edwin
    Gautam, Shiva
    [J]. NEUROLOGY, 2017, 88
  • [3] COMPLIANCE OF TUMOR TREATING ELECTRIC FIELDS THERAPY AND OVERALL SURVIVAL IN GLIOBLASTOMA
    Wong, Eric
    Fong, Johnson
    Lok, Edwin
    Gautam, Shiva
    [J]. NEURO-ONCOLOGY, 2016, 18 : 177 - 178
  • [4] Quantitative MR measurements in glioblastoma patients: Mean diffusivity with tumor treating fields plus standard therapy versus standard treatment alone
    Vymazal, Josef
    Zacek, Radovan
    Sroubek, Jan
    Klener, Jan
    Rulseh, Aaron M.
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [5] Quantitative MR Measurements of Mean Diffusivity in Glioblastoma Patients with Tumor Treating Fields Plus Standard Therapy versus Standard Treatment Alone
    Vymazal, J.
    Zacek, R.
    Sroubek, J.
    Klener, J.
    Rulseh, A. M.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : E367 - E367
  • [6] TUMOR-TREATING FIELDS THERAPY IS COMPATIBLE WITH STANDARD CHEMORADIOTHERAPY FOR GLIOBLASTOMA
    Stachelek, Gregory
    Grimm, Jimm
    Lim, Michael
    Bettegowda, Chetan
    Redmond, Kristin
    Kleinberg, Lawrence
    [J]. NEURO-ONCOLOGY, 2018, 20 : 228 - 228
  • [7] TUMOR TREATING FIELDS THERAPY IN A NEWLY DIAGNOSED GLIOBLASTOMA PATIENT WITH MULTIPLE SCLEROSIS
    Kassubek, R.
    Ludolph, A. C.
    [J]. NEURO-ONCOLOGY, 2018, 20 : 242 - 242
  • [8] The cost-effectiveness of tumor-treating fields therapy in patients with newly diagnosed glioblastoma
    Bernard-Arnoux, F.
    Lamure, M.
    Ducray, F.
    Aulagner, G.
    Honnorat, J.
    Armoiry, X.
    [J]. NEURO-ONCOLOGY, 2016, 18 (08) : 1129 - 1136
  • [9] Critical review of the addition of tumor treating fields (TTFields) to the existing standard of care for newly diagnosed glioblastoma patients
    Mehta, M.
    Wen, P.
    Nishikawa, R.
    Reardon, D.
    Peters, K.
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2017, 111 : 60 - 65
  • [10] Randomized Phase II trial of Tumor Treating Fields plus radiation therapy plus temozolamide compared to radiation therapy plus temozolomide in patients with newly diagnosed glioblastoma
    Grossman, Rachel
    Limon, Dror
    Bokstein, Felix
    Ben Harosh, Carmit
    Ram, Zvi
    [J]. CANCER RESEARCH, 2019, 79 (13)
12345